Literature DB >> 30659262

Reply to Bombard and Mighton.

Daniele Carrieri1, Heidi C Howard2,3, Angus J Clarke4, Vigdis Stefansdottir5, Martina C Cornel6, Carla G van El6, Francesca Forzano7.   

Abstract

Mesh：

Year:  2019        PMID： 30659262      PMCID： PMC6460587          DOI： 10.1038/s41431-018-0315-z

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  3 in total

1.  What is clinical utility and why should we care?

Authors:  L J Lesko; I Zineh; S-M Huang
Journal:  Clin Pharmacol Ther       Date:  2010-12       Impact factor: 6.875

2.  Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe.

Authors:  Fabio Sirchia; Daniele Carrieri; Sandi Dheensa; Caroline Benjamin; Hülya Kayserili; Christophe Cordier; Carla G van El; Peter D Turnpenny; Bela Melegh; Álvaro Mendes; Tanya F Halbersma-Konings; Irene M van Langen; Anneke M Lucassen; Angus J Clarke; Francesca Forzano; Susan E Kelly
Journal:  Eur J Hum Genet       Date:  2018-04-23       Impact factor: 4.246

3.  What is the clinical utility of genetic testing?

Authors:  Scott D Grosse; Muin J Khoury
Journal:  Genet Med       Date:  2006-07       Impact factor: 8.822
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.